Recombinant TAT-gelonin fusion toxin: Synthesis and characterization of heparin/protamine-regulated cell transduction
文献类型：期刊论文
| 作者 | Shin, Meong Cheol1,7; Zhao, Jingwen3; Zhang, Jian2,6; Huang, Yongzhuo5 ; He, Huining7; Wang, Mei4; Min, Kyoung Ah1; Yang, Victor C.1,7
|
| 刊名 | JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
 |
| 出版日期 | 2015-01 |
| 卷号 | 103期号:1页码:409-419 |
| 关键词 | gelonin TAT heparin protamine tumor |
| ISSN号 | 1549-3296 |
| DOI | 10.1002/jbm.a.35188 |
| 文献子类 | Article |
| 英文摘要 | Protein toxins, such as gelonin, are highly desirable anti-cancer drug candidates due to their unparalleled potency and repetitive reaction mechanism in inhibiting protein translation. However, for its potential application in cancer therapy, there remains the cell membrane barrier that allows permeation of only small molecules, which must be overcome. To address this challenge, we conjugated gelonin with a protein transduction domain (PTD), the TAT peptide, via genetic recombination. The chimeric TAT-gelonin fusion protein (TAT-Gel) retained equipotent N-glycosidase activity yet displayed greater cell uptake than unmodified recombinant gelonin (rGel), thereby yielding a significantly augmented cytotoxic activity. Remarkably, TAT-Gel displayed up to 177-fold lower IC50 (avg. 54.3 nM) than rGel (avg. IC50: 3640 nM) in tested cell lines. This enhanced cytotoxicity, however, also raised potential toxicity concerns due to the non-selectivity of PTD in its mediated cell transduction. To solve this problem, we investigated the plausibility of regulating the cell transduction of TAT-Gel via a reversible masking using heparin and protamine. Here, we demonstrated, both in vitro and in vivo, that the cell transduction of TAT-Gel can be completely curbed with heparin and yet this heparin block can be efficiently reversed by the addition of protamine. This reversible tight regulation of the cell transduction of TAT-Gel by heparin and protamine sheds light of possible application of TAT-Gel in achieving a highly effective yet safe drug therapy for the treatment of tumors. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 103A: 409-419, 2015. |
| WOS关键词 | PENETRATING PEPTIDES ; ASPARAGINASE THERAPY ; CANCER-TREATMENT ; IN-VITRO ; DELIVERY ; PROTEIN ; IMMUNOTOXIN ; CONJUGATION ; ENDOCYTOSIS ; CHALLENGES |
| 资助项目 | NSFC[81361140344] ; National Key Basic Research Program of China[2013CB932502] ; National Institutes of Health[CA114612] |
| WOS研究方向 | Engineering ; Materials Science |
| 语种 | 英语 |
| WOS记录号 | WOS:000345572100045 |
| 出版者 | WILEY |
| 源URL | [http://119.78.100.183/handle/2S10ELR8/276793]  |
| 专题 | 药物制剂研究中心 |
| 通讯作者 | Zhao, Jingwen |
| 作者单位 | 1.Univ Michigan, Dept Pharmaceut Sci, Coll Pharm, Ann Arbor, MI 48109 USA; 2.Soochow Univ, Dept Polymer Sci & Engn, Coll Chem Chem Engn & Mat Sci, Biomed Polymers Lab, Suzhou 215123, Peoples R China; 3.Tianjin Univ, Sch Pharmaceut Sci & Technol, Dept Mol & Cellular Pharmacol, Tianjin 300072, Peoples R China; 4.Xinjiang Med Univ, Coll Pharm, Urumqi 830011, Peoples R China 5.Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China; 6.Soochow Univ, Dept Polymer Sci & Engn, Coll Chem Chem Engn & Mat Sci, Jiangsu Key Lab Adv Funct Polymer Design & Applic, Suzhou 215123, Peoples R China; 7.Tianjin Med Univ, Sch Pharm, Tianjin Key Lab Technol Enabling Dev Clin Therape, Tianjin 300070, Peoples R China; |
| 推荐引用方式 GB/T 7714 | Shin, Meong Cheol,Zhao, Jingwen,Zhang, Jian,et al. Recombinant TAT-gelonin fusion toxin: Synthesis and characterization of heparin/protamine-regulated cell transduction[J]. JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A,2015,103(1):409-419. |
| APA | Shin, Meong Cheol.,Zhao, Jingwen.,Zhang, Jian.,Huang, Yongzhuo.,He, Huining.,...&Yang, Victor C..(2015).Recombinant TAT-gelonin fusion toxin: Synthesis and characterization of heparin/protamine-regulated cell transduction.JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A,103(1),409-419. |
| MLA | Shin, Meong Cheol,et al."Recombinant TAT-gelonin fusion toxin: Synthesis and characterization of heparin/protamine-regulated cell transduction".JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A 103.1(2015):409-419. |
入库方式： OAI收割
来源：上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。